Cost-Effectiveness of the Self-Care Management System for Heart Failure
- PMID: 39802132
- PMCID: PMC11711784
- DOI: 10.1253/circrep.CR-24-0088
Cost-Effectiveness of the Self-Care Management System for Heart Failure
Abstract
Background: We recently reported that the self-care management system for heart failure (HF) decreased re-hospitalization for HF. In the present study we estimate the cost-effectiveness of this system.
Methods and results: We retrospectively enrolled 569 consecutive patients who were admitted for HF treatment at Kitano Hospital. In the present analysis, we sought to compare cardiovascular healthcare costs and the incremental cost-effective ratio (ICER), expressed as the cost per quality-adjusted life-years (QALY) gained, between patients using the self-care management system (n=153) and those not using the system (n=153) after propensity-score matching. To calculate the QALY, we used the New York Heart Association class and the corresponding scores of quality of life in every 3 months. The healthcare costs of cardiovascular disease were ¥129,747,016 in the user group and ¥156,427,032 in the non-user group, where 24 and 43 patients were hospitalized, respectively. The cost of this new system was ¥50,000 in the user group. The total costs were ¥129,797,016 in the user group and ¥156,427,032 in the non-user group. By using the system, the QALY increased from 0.653 to 0.686. The ICER was below 0 and the system was interpreted as cost-effective.
Conclusions: Use of the self-care management system is likely to be a cost-effective treatment for HF with the increase in QALY and the decrease in healthcare costs.
Keywords: Cost-effectiveness; Heart failure; Rehospitalization; Self-care management.
Copyright © 2025, THE JAPANESE CIRCULATION SOCIETY.
Conflict of interest statement
E.N., M. Inoko, H.F., M.Y., Y. Yamaji, and T. Hamaguchi received a research grant from Bayer Yakuhin, Ltd, Takeda Pharmaceutical CO., Ltd, Novartis Pharma K.K., and IQVIA Services Japan G.K., and a scholarship grant from IQVIA Services Japan G.K., and Research Institute of Production Development. The other authors have no conflicts of interest.
Figures




Similar articles
-
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.JAMA Cardiol. 2023 Nov 1;8(11):1041-1048. doi: 10.1001/jamacardio.2023.3216. JAMA Cardiol. 2023. PMID: 37755814 Free PMC article.
-
Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis.ESC Heart Fail. 2023 Oct;10(5):3046-3054. doi: 10.1002/ehf2.14496. Epub 2023 Aug 17. ESC Heart Fail. 2023. PMID: 37591524 Free PMC article.
-
Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.J Med Econ. 2018 Feb;21(2):174-181. doi: 10.1080/13696998.2017.1387119. Epub 2017 Oct 10. J Med Econ. 2018. PMID: 28959905
-
Cost-effectiveness analyses of sacubitril-valsartan for heart failure.Heart Fail Rev. 2021 Sep;26(5):1119-1130. doi: 10.1007/s10741-020-09956-6. Heart Fail Rev. 2021. PMID: 32405811 Review.
-
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217. J Manag Care Pharm. 2010. PMID: 20331326 Free PMC article. Review.
Cited by
-
Rationale and Protocol of the Registry for Contemporary Medical Management of Chronic Heart Failure With Mildly Reduced and Preserved Ejection Fraction - The PARACLETE Study.Circ Rep. 2025 May 14;7(6):491-496. doi: 10.1253/circrep.CR-24-0138. eCollection 2025 Jun 10. Circ Rep. 2025. PMID: 40497130 Free PMC article.
References
-
- Soundarraj D, Singh V, Satija V, Thakur RK.. Containing the cost of heart failure management: A focus on reducing readmissions. Heart Failure Clin 2017; 13: 21–28. - PubMed
-
- Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, et al.. Impending epidemic: Future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489–491. - PubMed
-
- Kanaoka K, Okayama S, Nakai M, Sumita Y, Nishimura K, Kawakami R, et al.. Hospitalization costs for patients with acute congestive heart failure in Japan. Circ J 2019; 83: 1025–1031. - PubMed
-
- Nakane E, Kato T, Tanaka N, Kuriyama T, Kimura K, Nishiwaki S, et al.. Association of the induction of a self-care management system with 1-year outcomes in patients hospitalized for heart failure. J Cardiol 2021; 77: 48–56. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous